JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benveniste, H.
Right arrow Articles by Volkow, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benveniste, H.
Right arrow Articles by Volkow, N. D.
Journal of Nuclear Medicine Vol. 44 No. 9 1522-1530
© 2003 by Society of Nuclear Medicine


Basic Science Investigations

Maternal-Fetal In Vivo Imaging: A Combined PET and MRI Study

Helene Benveniste, MD, PhD1,2, Joanna S. Fowler, PhD3, William D. Rooney, PhD3, Daryn H. Moller, MD2, W. Walter Backus, MD2, Donald A. Warner3, Pauline Carter, RN1, Payton King1, Bruce Scharf, DMV1,4, David A. Alexoff, BSE3, Yeming Ma, PhD1, Paul Vaska, PhD3, David Schlyer, PhD3 and Nora D. Volkow, MD1

1 Medical Department, Brookhaven National Laboratory, Upton, New York
2 Department of Anesthesiology, State University of New York Stony Brook, Stony Brook, New York
3 Chemistry Department, Brookhaven National Laboratory, Upton, New York
4 Division of Laboratory Animal Resources, State University of New York Brooklyn, Brooklyn, New York

An understanding of how drugs are transferred between mother and fetus during the gestational period is an important medical issue of relevance to both therapeutic drugs and drugs of abuse. Though there are several in vitro and in vivo methods to examine this issue, all have limitations. Furthermore, ethical and safety considerations generally preclude such studies in pregnant humans. PET and appropriately labeled compounds have the ability to provide information on both maternal-fetal drug pharmacokinetics and pharmacodynamics. We present here a nonhuman primate animal model and the methodology for combining PET and MRI to identify fetal organs and to measure maternal and fetal isotope distribution using 18F-FDG and a whole-body imaging protocol to demonstrate proof-of-principle. Methods: One nonpregnant nonhuman primate was used for determination of the anesthesia protocol and MRI methods and 3 pregnant nonhuman primates (Macaques radiata) weighing 4.5–7 kg were used for the imaging study and anesthetized with propofol (160–300 µg/kg/min). Anatomic T2-weighted MR images were acquired on a 4-T MR instrument. Subsequently, whole-body PET images were acquired 35 min after injection of 18F-FDG, and standardized uptake values (SUVs) were calculated. Image processing and coregistration were performed using commercial software. Results: All animals underwent uneventful general anesthesia for a period of up to 7 h. Coregistration of PET and MR images allowed identification of fetal organs and demonstrated that 18F-FDG readily crosses the placenta and that 18F accumulates in both maternal and fetal brain, heart, and bladder. Brain SUVs averaged 1.95 ± 0.08 (mean ± SD) and 1.58 ± 0.11 for mothers and fetuses, respectively. Monkeys delivered healthy babies after a normal gestational term of 170 d following the PET/MRI study. Conclusion: The pregnant macaque in combination with PET and MRI technology allows the measurement of radioisotope distribution in maternal and fetal organs. This demonstrates the potential for noninvasively measuring the transfer of drugs across the placenta and for measuring the fetal drug distribution. It also opens up the possibility for studying binding and elimination as well as the effects of a drug on specific cellular elements and physiologic processes during the gestational period in a primate model.

Key Words: maternal-fetal exchange • imaging • in vivo • primate




This article has been cited by other articles:


Home page
JNMHome page
P. Zanotti-Fregonara, C. Champion, R. Trebossen, R. Maroy, J.-Y. Devaux, and E. Hindie
Estimation of the {beta}+ Dose to the Embryo Resulting from 18F-FDG Administration During Early Pregnancy
J. Nucl. Med., April 1, 2008; 49(4): 679 - 682.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
C.H. t. Hove, J.M. Zijlstra-Baalbergen, E.F.I. Comans, and R.M. van Elburg
An unusual hotspot in a young woman with Hodgkin's lymphoma
Haematologica, January 1, 2008; 93(1): e14 - e15.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
D. Pereg, G. Koren, and M. Lishner
The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy
Haematologica, September 1, 2007; 92(9): 1230 - 1237.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Benveniste, J. S. Fowler, W. Rooney, Y.-S. Ding, A. L. Baumann, D. H. Moller, C. Du, W. Backus, J. Logan, P. Carter, et al.
Maternal and Fetal 11C-Cocaine Uptake and Kinetics Measured In Vivo by Combined PET and MRI in Pregnant Nonhuman Primates
J. Nucl. Med., February 1, 2005; 46(2): 312 - 320.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. G. Stabin
Proposed Addendum to Previously Published Fetal Dose Estimate Tables for 18F-FDG
J. Nucl. Med., April 1, 2004; 45(4): 634 - 635.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.